|
1
|
Diener MK, Knaebel HP, Heukaufer C, Antes
G, Büchler MW and Seiler CM: A systematic review and meta-analysis
of pylorus-preserving versus classical pancreaticoduodenectomy for
surgical treatment of periampullary and pancreatic carcinoma. Ann
Surg. 245:187–200. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang W, Xiong JJ, Wan MH, Szatmary P,
Bharucha S, Gomatos I, Nunes QM, Xia Q, Sutton R and Liu XB:
Meta-analysis of subtotal stomach-preserving
pancreaticoduodenectomy vs. pylorus preserving
pancreaticoduodenectomy. World J Gastroenterol. 21:6361–6373. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Watson K: Carcinoma of ampulla of vater
successful radical resection. Br J Surg. 31:368–373. 1944.
View Article : Google Scholar
|
|
4
|
Traverso LW and Longmire WJ: Preservation
of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet.
146:959–962. 1978.PubMed/NCBI
|
|
5
|
Hiyoshi M, Chijiiwa K, Ohuchida J, Imamura
N and Nagano M: Comparative study of gastric emptying and
nutritional status after pylorus-preserving vs. subtotal
stomach-preserving pancreaticoduodenectomy. Hepatogastroenterology.
59:1018–1022. 2012.PubMed/NCBI
|
|
6
|
Zhao R, Chang Y, Wang X, Zhang P, Zhang C
and Lian P: Pylorus-preserving pancreaticoduodenectomy versus
standard pancreaticoduodenectomy in the treatment of duodenal
papilla carcinoma. Oncol Lett. 15:6368–6376. 2018.PubMed/NCBI
|
|
7
|
Kojima M, Hosoda H, Date Y, Nakazato M,
Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing
acylated peptide from stomach. Nature. 402:656–660. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Asakawa A, Inui A, Kaga T, Yuzuriha H,
Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA and
Kasuga M: Ghrelin is an appetite-stimulatory signal from stomach
with structural resemblance to motilin. Gastroenterology.
120:337–345. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Muccioli G, Tschöp M, Papotti M, Deghenghi
R, Heiman M and Ghigo E: Neuroendocrine and peripheral activities
of ghrelin: Implications in metabolism and obesity. Eur J
Pharmacol. 440:235–254. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takachi K, Doki Y, Ishikawa O, Miyashiro
I, Sasaki Y, Ohigashi H, Murata K, Nakajima H, Hosoda H, Kangawa K,
et al: Postoperative ghrelin levels and delayed recovery from body
weight loss after distal or total gastrectomy. J Surg Res. 130:1–7.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Doki Y, Takachi K, Ishikawa O, Miyashiro
I, Sasaki Y, Ohigashi H, Nakajima H, Hosoda H, Kangawa K, Sasakuma
F, et al: Ghrelin reduction after esophageal substitution and its
correlation to postoperative body weight loss in esophageal cancer
patients. Surgery. 139:797–805. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takiguchi S, Murakami K, Yanagimoto Y,
Takata A, Miyazaki Y, Mori M and Doki Y: Clinical application of
ghrelin in the field of surgery. Surg Today. 45:801–807. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsuchimochi W, Kyoraku I, Yamaguchi H,
Toshinai K, Shiomi K, Kangawa K and Nakazato M: Ghrelin prevents
the development of experimental diabetic neuropathy in rodents. Eur
J Pharmacol. 702:187–193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yano Y, Nakazato M, Toshinai K, Inokuchi
T, Matsuda S, Hidaka T, Hayakawa M, Kangawa K, Shimada K and Kario
K: Circulating des-acyl ghrelin improves cardiovascular risk
prediction in older hypertensive patients. Am J Hypertens.
27:727–733. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanda M, Fujii T, Kodera Y, Nagai S,
Takeda S and Nakao A: Nutritional predictors of postoperative
outcome in pancreatic cancer. Br J Surg. 98:268–274. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang P, Xi M, Li QQ, He LR, Liu SL, Zhao
L, Shen JX and Liu MZ: The modified glasgow prognostic score is an
independent prognostic factor in patients with inoperable thoracic
esophageal squamous cell carcinoma undergoing chemoradiotherapy. J
Cancer. 5:689–695. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen P, Fang M, Wan Q, Zhang X, Song T and
Wu S: High-sensitivity modified Glasgow prognostic score (HS-mGPS)
is superior to the mGPS in esophageal cancer patients treated with
chemoradiotherapy. Oncotarget. 8:99861–99870. 2017.PubMed/NCBI
|
|
18
|
Cui Y, Li J, Cao YH, Liu MY, Shi ZX and
Gao TH: Predictive and prognostic significance of high-sensitivity
modified glasgow prognostic score (HS-mGPS) in advanced gastric
cancer patients treated with neoadjuvant chemotherapy. Zhonghua
Zhong Liu Za Zhi. 39:195–200. 2017.(In Chinese). PubMed/NCBI
|
|
19
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM classification of malignant tumors8th.
Wiley-Blackwell; 2017
|
|
20
|
Dindo D, Demartines N and Clavien PA:
Classification of surgical complications: A new proposal with
evaluation in a cohort of 6336 patients and results of a survey.
Ann Surg. 240:205–213. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hiyoshi M, Chijiiwa K, Fujii Y, Imamura N,
Nagano M and Ohuchida J: Usefulness of drain amylase, serum
C-reactive protein levels and body temperature to predict
postoperative pancreatic fistula after pancreaticoduodenectomy.
World J Surg. 37:2436–2442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kakita A, Yoshida M and Takahashi T:
History of pancreaticojejunostomy in pancreaticoduodenectomy:
Development of a more reliable anastomosis technique. J
Hepatobiliary Pancreat Surg. 8:230–237. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chijiiwa K, Imamura N, Ohuchida J, Hiyoshi
M, Nagano M, Otani K, Kai M and Kondo K: Prospective randomized
controlled study of gastric emptying assessed by (13)C-acetate
breath test after pylorus-preserving pancreaticoduodenectomy:
Comparison between antecolic and vertical retrocolic
duodenojejunostomy. J Hepatobiliary Pancreat Surg. 16:49–55. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Uesaka K, Boku N, Fukutomi A, Okamura Y,
Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto
H, et al: Adjuvant chemotherapy of S-1 versus gemcitabine for
resected pancreatic cancer: A phase 3, open-label, randomised,
non-inferiority trial (JASPAC 01). Lancet. 388:248–257. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nanashima A, Murakami G, Takagi K, Arai J,
Sumida Y, Kodama T and Nagayasu T: Relationship between serum
ghrelin level and physiology in patients who underwent hepatectomy
and pancreatectomy. Acta Med Nagasaki. 61:55–60. 2017.
|
|
26
|
Sasaki K, Asaoka T, Eguchi H, Fukuda Y,
Iwagami Y, Yamada D, Miyazaki Y, Noda T, Takahashi T, Gotoh K, et
al: Plasma ghrelin suppression as an early predictor for
postoperative complications after pancreatoduodenectomy.
Pancreatology. 18:73–78. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takiguchi S, Takata A, Murakami K,
Miyazaki Y, Yanagimoto Y, Kurokawa Y, Takahashi T, Mori M and Doki
Y: Clinical application of ghrelin administration for gastric
cancer patients undergoing gastrectomy. Gastric Cancer. 17:200–205.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kasai C, Sugimoto K, Moritani I, Tanaka J,
Oya Y, Inoue H, Tameda M, Shiraki K, Ito M, Takei Y and Takase K:
Changes in plasma ghrelin and leptin levels in patients with peptic
ulcer and gastritis following eradication of Helicobacter
pylori infection. BMC Gastroenterol. 16:1192016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shiiya T, Nakazato M, Mizuta M, Date Y,
Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K and Matsukura S:
Plasma ghrelin levels in lean and obese humans and the effect of
glucose on ghrelin secretion. J Clin Endocrinol Metab. 87:240–244.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Date Y, Murakami N, Toshinai K, Matsukura
S, Niijima A, Matsuo H, Kangawa K and Nakazato M: The role of the
gastric afferent vagal nerve in ghrelin-induced feeding and growth
hormone secretion in rats. Gastroenterology. 123:1120–1128. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kumamoto Y, Kaizu T, Tajima H, Nishizawa
N, Ei S, Igarashi K and Watanabe M: Neutrophil-to-lymphocyte ratio
as a predictor of postoperative morbidity in patients with distal
cholangiocarcinoma. Mol Clin Oncol. 9:362–368. 2018.PubMed/NCBI
|
|
32
|
Duxbury MS, Waseem T, Ito H, Robinson MK,
Zinner MJ, Ashley SW and Whang EE: Ghrelin promotes pancreatic
adenocarcinoma cellular proliferation and invasiveness. Biochem
Biophys Res Commun. 309:464–468. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jeffery PL, Murray RE, Yeh AH, McNamara
JF, Duncan RP, Francis GD, Herington AC and Chopin LK: Expression
and function of the ghrelin axis, including a novel preproghrelin
isoform, in human breast cancer tissues and cell lines. Endocr
Relat Cancer. 12:839–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin TC, Liu YP, Chan YC, Su CY, Lin YF,
Hsu SL, Yang CS and Hsiao M: Ghrelin promotes renal cell carcinoma
metastasis via Snail activation and is associated with poor
prognosis. J Pathol. 237:50–61. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Waseem T, Javaid-Ur-Rehman, Ahmad F, Azam
M and Qureshi MA: Role of ghrelin axis in colorectal cancer: A
novel association. Peptides. 29:1369–1376. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin TC and Hsiao M: Ghrelin and cancer
progression. Biochim Biophys Acta Rev Cancer. 1868:51–57. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yanagi S, Sato T, Kangawa K and Nakazato
M: The homeostatic force of ghrelin. Cell Metab. 27:786–804. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zeng X, Chen S, Lin Y and Ke Z: Acylated
and unacylated ghrelin inhibit apoptosis in myoblasts cocultured
with colon carcinoma cells. Oncol Rep. 39:1387–1395.
2018.PubMed/NCBI
|
|
39
|
Garcia JM, Garcia-Touza M, Hijazi RA,
Taffet G, Epner D, Mann D, Smith RG, Cunningham GR and Marcelli M:
Active ghrelin levels and active to total ghrelin ratio in
cancer-induced cachexia. J Clin Endocrinol Metab. 90:2920–2926.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kerem M, Ferahkose Z, Yilmaz UT, Pasaoglu
H, Ofluoglu E, Bedirli A, Salman B, Sahin TT and Akin M: Adipokines
and ghrelin in gastric cancer cachexia. World J Gastroenterol.
14:3633–3641. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ozola Zalite I, Zykus R, Francisco
Gonzalez M, Saygili F, Pukitis A, Gaujoux S, Charnley RM and Lyadov
V: Influence of cachexia and sarcopenia on survival in pancreatic
ductal adenocarcinoma: A systematic review. Pancreatology.
15:19–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Abe K, Uwagawa T, Haruki K, Takano Y, Onda
S, Sakamoto T, Gocho T and Yanaga K: Effects of ω-3 fatty acid
supplementation in patients with bile duct or pancreatic cancer
undergoing chemotherapy. Anticancer Res. 38:2369–2375.
2018.PubMed/NCBI
|
